# COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function

> **NCT01974154** · — · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 206 (actual)

## Conditions studied

- COPD
- Smoking

## Interventions

- **OTHER:** Cohort I
- **OTHER:** Cohort II

## Key facts

- **NCT ID:** NCT01974154
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-12
- **Primary completion:** 2019-05
- **Final completion:** 2019-05
- **Target enrollment:** 206 (ACTUAL)
- **Why stopped:** Lack of funding.
- **Last updated:** 2020-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01974154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01974154, "COPD Metabolome, Smoking Oxidants and Aberrant Ciliated Cell Function". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01974154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*